Vimarsana
Biggest News Aggregation in the World

Page 5 - Dave Fredrickson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dave Fredrickson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dave Fredrickson Today - Breaking & Trending Today

AstraZeneca's Tagrisso plus chemotherapy appoved for lung cancer in the US - Vimarsana News

AstraZeneca's Tagrisso plus chemotherapy appoved for lung cancer in the US

AstraZeneca's Tagrisso approved in the US for EGFRm non-small cell lung cancer with chemotherapy. FLAURA2 trial results show significant benefit.

Osimertinib With Chemo Gains FDA Approval for EGFR-Mutated NSCLC - Vimarsana News

Osimertinib With Chemo Gains FDA Approval for EGFR-Mutated NSCLC

Besides the new approval, AstraZeneca released preliminary results for LAURA evaluating osimertinib after chemoradiotherapy.

Source: ajmc.com
AstraZeneca's Tagrisso approved as an important new treatment option - Vimarsana News

AstraZeneca's Tagrisso approved as an important new treatment option

Patients in the US with epidermal growth factor receptor mutated (EGFRm) advanced lung cancer can now receive an important new treatment option delaying disease progression by nearly nine additional months.

FDA Approves Osimertinib With Chemotherapy for EGFRm NSCLC - Vimarsana News

FDA Approves Osimertinib With Chemotherapy for EGFRm NSCLC

Osimertinib was previously approved as a monotherapy, the first-in-line global standard of care, for non–small cell lung cancer indications.

AstraZeneca Plc (AZN) Q4 2023 Earnings Call Transcript - Vimarsana News

AstraZeneca Plc (AZN) Q4 2023 Earnings Call Transcript

AZN earnings call for the period ending December 31, 2023.

Source: yahoo.com